FDA Adverse Event Injury Summary report: N

ULTRAFLEX IAB: 7.5FR 40CC

MDR report key: 16407741 · Received February 21, 2023

Report

Report Number
3010532612-2023-00094
Event Type
Injury
Date Received
February 21, 2023
Date of Event
December 30, 2022
Report Date
February 6, 2023
Manufacturer
ARROW INTERNATIONAL LLC
Product Code
DSP
UDI-DI
10801902161946
PMA / PMN Number
K000729
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

QN#(B)(4). COMPLAINT VERIFICATION TESTING COULD NOT BE PERFORMED AS NO SAMPLE WAS RETURNED FOR ANALYSIS. A DEVICE HISTORY RECORD REVIEW WAS PERFORMED, AND NO RELEVANT FINDINGS WERE IDENTIFIED. WITHOUT THE DEVICE TO EVALUATE, THE COMPLAINT COULD NOT BE CONFIRMED, AND THE PROBABLE CAUSE COULD NOT BE DETERMINED FROM THE AVAILABLE INFORMATION. TELEFLEX WILL CONTINUE TO MONITOR AND TREND FOR REPORTS OF THIS NATURE. OTHER REMARKS: N/A. CORRECTED DATA: N/A.

Additional Manufacturer Narrative · 0

(B)(4).

Description of Event or Problem · 0

IT WAS REPORTED THAT THERE WERE THREE DIFFERENT EVENTS ON THREE DIFFERENT PATIENTS IN THE LAST SIX MONTHS. THE REPORT STATES, "IN OC TOBER 2022 THE PATIENT HAD A VENTRICULAR TACHYCARDIA (VT) ARREST, CARDIOGENIC SHOCK, AND WAS LISTED FOR HEART TRANSPLANT. ADMITTED ON (B)(6)22 FOR ADVANCED THERAPIES AND VAD/TRANSPLANT EVALUATION. ON (B)(6)22, AN ULTRA FLEX 7F 40 CC IABP PLACED IN THE RIGHT FEMORAL ARTERY FOR WORSENING CARDIOGENIC SHOCK. THE PATIENT WAS HEPARINIZED WITH THERAPEUTIC ANTI-XA AND THE PATIENT WAS ON 1:1 IABP. LATER THAT DAY, THE PATIENT DEVELOPED ABDOMINAL PAIN, WHICH WAS FOUND ON CTA TO BE SECONDARY TO ARTERIAL THROMBI IN THE RIGHT HEPATIC ARTERY AND ITS PROXIMAL BRANCHES AND IN SEGMENTAL BRANCHES OF THE LEFT KIDNEY, WITH MULTIPLE RENAL INFARCTS. ON (B)(6)22, THE IABP WAS DISCONTINUED DUE TO THROMBOTIC/EMBOLIC COMPLICATIONS - IABP-RELATED ARTERIAL EMBOLISM. HE ALSO DEVELOPED LOSS OF DISTAL PULSES IN THE RIGHT LOWER EXTREMITY REQUIRING SURGERY AS BELOW. HEPARIN INDUCED THROMBOCYTOPENIA WAS THOUGHT TO BE UNLIKELY AFTER CLINICAL AND LABORATORY ASSESSMENT. THE PATIENT WAS ANTICOAGULATED WITH BIVALRUDIN. HE HAD WORSENING ACUTE KIDNEY INJURY ON CHRONIC KIDNEY INJURY. ANOTHER BALLOON WAS NOT USED. ON (B)(6)23, THE PATIENT UNDERWENT AN EMBOLECTOMY/THROMBECTOMY OF THE RIGHT LEG. ON (B)(6)23, A BIVENTRICULAR ASSIST DEVICE (BIVAD) WAS PLACED. THE PATIENT IS CURRENTLY STILL ADMITTED".

Description of Event or Problem · 0

IT WAS REPORTED THAT THERE WERE THREE DIFFERENT EVENTS ON THREE DIFFERENT PATIENTS IN THE LAST SIX MONTHS. THE REPORT STATES, "IN OC TOBER 2022 THE PATIENT HAD A VENTRICULAR TACHYCARDIA (VT) ARREST, CARDIOGENIC SHOCK, AND WAS LISTED FOR HEART TRANSPLANT. ADMITTED ON 12/4/22 FOR ADVANCED THERAPIES AND VAD/TRANSPLANT EVALUATION. ON (B)(6) 2022, AN ULTRA FLEX 7F 40 CC IABP PLACED IN THE RIGHT FEMORAL ARTERY FOR WORSENING CARDIOGENIC SHOCK. THE PATIENT WAS HEPARINIZED WITH THERAPEUTIC ANTI-XA AND THE PATIENT WAS ON 1:1 IABP. LATER THAT DAY, THE PATIENT DEVELOPED ABDOMINAL PAIN, WHICH WAS FOUND ON CTA TO BE SECONDARY TO ARTERIAL THROMBI IN THE RIGHT HEPATIC ARTERY AND ITS PROXIMAL BRANCHES AND IN SEGMENTAL BRANCHES OF THE LEFT KIDNEY, WITH MULTIPLE RENAL INFARCTS. ON 12/31/22, THE IABP WAS DISCONTINUED DUE TO THROMBOTIC/EMBOLIC COMPLICATIONS - IABP-RELATED ARTERIAL EMBOLISM. HE ALSO DEVELOPED LOSS OF DISTAL PULSES IN THE RIGHT LOWER EXTREMITY REQUIRING SURGERY AS BELOW. HEPARIN INDUCED THROMBOCYTOPENIA WAS THOUGHT TO BE UNLIKELY AFTER CLINICAL AND LABORATORY ASSESSMENT. THE PATIENT WAS ANTICOAGULATED WITH BIVALRUDIN. HE HAD WORSENING ACUTE KIDNEY INJURY ON CHRONIC KIDNEY INJURY. ANOTHER BALLOON WAS NOT USED. ON 1/3/23, THE PATIENT UNDERWENT AN EMBOLECTOMY/THROMBECTOMY OF THE RIGHT LEG. ON 1/10/23, A BIVENTRICULAR ASSIST DEVICE (BIVAD) WAS PLACED. THE PATIENT IS CURRENTLY STILL ADMITTED".

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
926607 ULTRAFLEX IAB: 7.5FR 40CC SYSTEM, BALLOON, INTRA-AORTIC DSP ARROW INTERNATIONAL LLC IPN915322 UNKNOWN 10801902161946

Patients

Seq Age Sex Outcome Treatment
1 Male